Zhejiang Jingxin Pharmaceutical announcement: In the first half of 2024, the company achieved revenue of 2.15 billion yuan, a year-on-year increase of 11.02%. The net income attributable to shareholders of the listed company was 0.402 billion yuan, a year-on-year increase of 27.28%. Net income attributable to shareholders of listed companies after deducting non-recurring gains and losses was 0.334 billion yuan, a year-on-year increase of 15.19%.
京新药业：上半年净利润增长27.28%
Zhejiang Jingxin Pharmaceutical: net income increased by 27.28% in the first half of the year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.